GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Epithelial Pyroptosis in Oral Tissues Triggers TREM1+ Macrophage Recruitment and Th17 Cell Activation

by GOAI
Share To

Researchers have identified a key mechanism in oral mucosal immunity that highlights how inflammation in oral tissues is initiated and intensified. The study focuses on epithelial cell pyroptosis, a form of inflammatory programmed cell death, and its role in activating specific immune responses. Findings indicate that this process mobilizes TREM1+ macrophages, a specialized subset of immune cells, which subsequently leads to the activation of Th17 cells, an important component of adaptive immunity.

The research provides detailed insight into how epithelial pyroptosis acts as a trigger for immune system activity within oral tissues. Pyroptotic epithelial cells release signals that recruit TREM1+ macrophages to the site of inflammation. These macrophages then amplify the inflammatory response by interacting with Th17 cells, which are known for their role in combating infections and contributing to autoimmune conditions. The study sheds light on the interplay between innate and adaptive immunity in oral health and disease, offering new perspectives on inflammatory processes at the cellular level.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top